Search

everythinglearnresearchcommunity

for

Search:↓

This method is effective for needle-free HIV-1 vaccination by activating immune responses in the skin.

Biomimetic nanovesicles can speed up diabetic wound healing by regulating immune cell behavior and metabolism.

New, effective treatments for alopecia areata require innovative approaches targeting the immune system.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Targeting TRP channels may help reduce excessive scarring.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Targeting specific cell interactions may help treat skin fibrosis.

Targeted immune modulation can help achieve stable remission in alopecia areata.

Targeting macrophages may improve wound healing.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Potential therapeutic targets for scarring hair loss are identified.

New drug targets for hair loss treatment were identified by studying cell interactions in hair follicles.

Targeting Vδ1+T-cells may help treat alopecia areata.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Early biopsy and targeting inflammation can improve treatment for hair loss in androgenetic alopecia.

Alopecia areata may be treated by targeting immune system imbalances.

Erianin may effectively treat alopecia areata by targeting the immune system.

Adipokines affect skin health and could be targeted for treating skin diseases.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Alopecia areata is an autoimmune disease that targets hair follicles.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

FOXN1 gene variants cause low T cells and immune issues from birth.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

Neuroregulation is crucial for skin wound healing and can be targeted to improve recovery.

TRPV4 channel affects skin health and could be a target for treating skin disorders.